Jeffrey N Simmons Elanco Animal Health Inc (ELAN) insider trading activity

Jeffrey N Simmons is PRESIDENT, CEO AND DIRECTOR of Elanco Animal Health Inc. Currently has a direct ownership of 1.8 Million shares of ELAN, which is worth approximately $40.1 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 265,252 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.8M

0% 3M change

32.87% 12M change

Total Value Held $40.1 Million

Jeffrey N Simmons Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	BUY Grant, award, or other acquisition	-	265,252 Added 12.83%	1,802,379 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$845,803 $11.17 p/Share	75,721 Reduced 4.69%	1,537,127 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$2,201,241 $11.24 p/Share	195,840 Reduced 10.83%	1,612,848 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	449,408 Added 19.9%	1,808,688 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$176,081 $15.99 p/Share	11,012 Reduced 0.81%	1,356,455 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$776,252 $16.03 p/Share	48,425 Reduced 3.42%	1,367,467 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	187,150 Added 11.67%	1,415,892 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$1,062,114 $16.46 p/Share	64,527 Reduced 4.99%	1,228,742 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	148,084 Added 10.27%	1,293,269 Common Stock
Mar 05 2023	SELL Payment of exercise price or tax liability	$118,725 $11.1 p/Share	10,696 Reduced 0.93%	1,142,569 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$1,518,080 $11.01 p/Share	137,882 Reduced 10.68%	1,153,265 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$100,730 $11.01 p/Share	9,149 Reduced 0.93%	974,761 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	316,386 Added 19.68%	1,291,147 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$142,574 $11.26 p/Share	12,662 Reduced 1.68%	742,369 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	248,668 Added 20.06%	991,037 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$298,730 $27.95 p/Share	10,688 Reduced 1.4%	752,986 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$257,491 $29.0 p/Share	8,879 Reduced 1.15%	763,674 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$145,597 $28.94 p/Share	5,031 Reduced 0.65%	772,553 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	88,114 Added 10.18%	777,584 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$2,414,789 $25.98 p/Share	92,948 Reduced 11.88%	689,470 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	229,655 Added 22.69%	782,418 Common Stock
Oct 20 2021	SELL Payment of exercise price or tax liability	$532,299 $33.66 p/Share	15,814 Reduced 2.78%	552,763 Common Stock
Aug 11 2021	BUY Open market or private purchase	$500,445 $29.7 p/Share	16,850 Added 2.88%	568,577 Common Stock
Mar 05 2021	BUY Grant, award, or other acquisition	-	74,374 Added 11.88%	551,727 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$287,147 $32.34 p/Share	8,879 Reduced 1.83%	477,353 Common Stock

Also insider at

LLY

ELI LILLY & Co Healthcare

SVP&Pres. Elanco Animal Health

JNS